As public health experts anticipate a rise in COVID-19 infections this summer, ensuring access to antiviral treatments for older adults and those with existing health conditions that make them vulnerable to serious illness is more important than ever.
CVEEP held a briefing featuring leading healthcare voices for an in-depth discussion on the current treatment landscape, highlighting the essential role antivirals play in preventing severe illness and hospitalization. The conversation explored key barriers to access, including under-prescription, cost, and insurance coverage, as well as strategies to raise awareness, improve uptake, and ensure that vulnerable populations can receive these life-saving treatments without delay.
Panelists included:
